Medicare Enrolled

Dr. Robert Wolfe, M.D.

Critical Care Medicine · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8631 W 3RD ST, Los Angeles, CA 90048
3106573792
In practice since 2006 (19 years)
NPI: 1285726216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wolfe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wolfe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wolfe

Dr. Robert Wolfe is a critical care medicine specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wolfe performed 3,896 Medicare services across 2,480 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wolfe received a total of $4,157 from 32 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wolfe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in CA $4,157 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,896
Medicare services
Top 5% in CA for critical care medicine
2,480
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~205 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,207 $101 $366
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
1,047 $23 $116
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
378 $73 $276
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
331 $66 $225
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
165 $17 $65
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
113 $140 $549
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
111 $144 $518
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
103 $109 $423
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
81 $15 $54
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
71 $12 $69
New patient office visit, complex (60-74 min) 69 $166 $556
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
62 $78 $300
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
50 $145 $551
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
39 $100 $339
Positive pressure ventilator therapy
A therapy procedure that uses a positive pressure ventilator to assist with breathing.
16 $56 $214
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
15 $109 $421
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
13 $35 $250
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
13 $52 $100
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
12 $29 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,157
Total received (2018-2024)
Avg $594/year across 7 years
Top 24% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,112 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$385
2022
$688
2021
$229
2020
$550
2019
$1,329
2018
$959

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Electromed, Inc.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$852
GlaxoSmithKline, LLC.
$758
Novartis Pharmaceuticals Corporation
$347
Boehringer Ingelheim Pharmaceuticals, Inc.
$309
Insmed, Inc.
$270
Philips Electronics North America Corporation
$210
Genentech USA, Inc.
$193
Grifols USA, LLC
$115
Sunovion Pharmaceuticals Inc.
$91
Mylan Specialty L.P.
$90
Electromed, Inc.
$88
Teva Pharmaceuticals USA, Inc.
$82
Covis Pharma GmBH
$80
Nabriva Therapeutics, plc
$77
AbbVie Inc.
$64
Mallinckrodt Enterprises LLC
$59
Amgen Inc.
$53
Jazz Pharmaceuticals Inc.
$46
Circassia Pharmaceuticals Inc
$45
Bayer HealthCare Pharmaceuticals Inc.
$42
Harmony Biosciences LLC
$41
Actelion Pharmaceuticals US, Inc.
$38
ARBOR PHARMACEUTICALS, INC.
$31
Breathe Technologies, Inc.
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Regeneron Healthcare Solutions, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
GENZYME CORPORATION
$19
Mallinckrodt Hospital Products Inc.
$17
Pulmonx Corporation
$17
Allergan Inc.
$13
Paratek Pharmaceuticals, Inc.
$12
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) InCourage · ACTHAR · ALVESCO · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · DALVANCE · DUPIXENT · Esbriet · FASENRA · Horizant · Life2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · Trilogy 100 · Utibron · Wakix · Wellcentive Undiv · XIFAXAN · XOLAIR · XYWAV · Xenleta · Xolair · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a critical care medicine specialist in Los Angeles?
Compare critical care medicines in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
151
Per 100K population
1.5
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wolfe is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wolfe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wolfe performed 1,207 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wolfe receive payments from pharmaceutical companies?
Yes. Dr. Wolfe received a total of $4,157 from 32 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wolfe's costs compare to other critical care medicines in Los Angeles?
Dr. Wolfe's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wolfe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →